Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AB Technology is a Japanese biotechnology company specializing in the development and manufacture of high-performance cell culture media and reagents for regenerative medicine and cell therapy. The company focuses on providing serum-free and chemically defined media that support the expansion of various cell types, including mesenchymal stem cells (MSCs) and T-cells, while ensuring safety and consistency for clinical applications. Beyond media production, AB Technology offers contract manufacturing and cell processing services to support the commercialization of advanced therapies. Their products are designed to meet the rigorous quality standards required for both research and clinical-grade manufacturing in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AB Technology.